Skip to main content

Priority-driven Collaborative Cancer Research Scheme


Cancer Australia has established the Priority-driven Collaborative Cancer Research Scheme to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.


The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia.

This funding scheme helps to:

  • coordinate funding of priority-driven cancer research at the national level,
  • foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
  • foster consumer participation in cancer research, from design to implementation.

Working with the National Health and Medical Research Council (NHMRC)

This research scheme is managed by Cancer Australia and the agency collaborates with the NHMRC in this grant scheme. The NHMRC facilitates registration and initial assessment of applications, and endorses grants funded through this scheme in recognition of their scientific merit.

Successful applicants for 2021 Round

On 15 December 2021, the Australian Government announced successful applicants in the 2021 round of the Priority-driven Collaborative Cancer Research Scheme, proudly supported by Cancer Australia, Can Too, Cure Cancer, Leukaemia Foundation, Lung Foundation Australia, My Room Children’s Cancer Charity Ltd, National Breast Cancer Foundation, Pancare Foundation, and The Kids’ Cancer Project.

Successful grants in the 2021 PdCCRS round are as follows:

Buchanan, Daniel
Victorian Comprehensive Cancer Centre, University of Melbourne
Linking gut bacteria to the development of early onset colorectal cancer using multi-omic profiling
Funded by: Cancer Australia

Greer, Peter
University of Newcastle
SEAFARER – Is radiation therapy patient specific quality assurance in Australia effective?
Funded by: Cancer Australia

Hickey, Theresa
University of Adelaide
Arming androgen receptors to transform endocrine therapy for ER+ breast cancer
Funded by: Cancer Australia

Hopper, John
University of Melbourne
Applying artificial intelligence, epidemiological thinking and the perspectives of women and their radiologists to address the problem of dense breasts.
Funded by: Cancer Australia

Kulasinghe, Arutha
University of Queensland
Funded by: Cancer Australia and Can Too Foundation

Macrae, Finlay
Melbourne Health
CaPP3 Australia: A randomised double blind dose non-inferiority trial of aspirin in Lynch syndrome with open label extension.
Funded by: Cancer Australia

Noll, Jacqueline
The University of Adelaide
Investigating mechanisms of relapse in high-risk paediatric acute lymphoblastic leukaemia
Funded by: My Room Children’s Cancer Charity Limited

Purton, Louise
St. Vincent’s Institute of Medical Research
Targeting HOXA1-expressing stem cells to improve therapies for myelodysplastic syndromes.
Funded by: Cancer Australia

Brosda, Sandra
The University of Queensland
Investigating the spatial and temporal tumour evolution to improve precision medicine in patients with oesophageal adenocarcinoma
Funded by: Cure Cancer

Castano-Rodriguez, Natalia
The University of New South Wales
Understanding the crosstalk between autophagy and microbial lactate in stomach cancer
Funded by: Cancer Australia and Pancare Foundation

Colino-Sanguino, Yolanda
Children's Cancer Institute, The University of New South Wales
Modelling epigenetic reprograming as immunotherapy for metastatic breast cancer
Funded by: Cancer Australia and Can Too

Guillerey, Camille
Mater Research Institute, The University of Queensland
Utilising cord blood-derived Natural Killer cells to prevent post-transplant relapse in Childhood Leukaemia
Funded by: Cancer Australia, Leukaemia Foundation, My Room Children’s Cancer Charity Ltd and The Kids’ Cancer Project

Hiwase, Devendra
Central Adelaide Local Health Network, The University of Adelaide
Identifying synthetic lethal and microenvironmental targets to improve outcome of therapy-related myeloid neoplasms
Funded by: Cancer Australia

Janaththani, Panchadsaram
Queensland University of Technology
Alternative splicing of Iroquois Homeobox-4 (IRX4) as a mediator of androgen signalling in aggressive prostate cancer
Funded by: Cancer Australia and Cure Cancer

Keall, Paul
University of Sydney
Dynamic cancer targeting for radiation therapy patients
Funded by: Cancer Australia

McDonnell, Alison
Telethon Kids Institute on behalf of the Centre for Child Health Research, University of Western Australia
Prognostic value of pleural effusion-derived tissue resident memory T cells
Funded by: Cancer Australia

Naeini, Marjan
The Council of the Queensland Institute of Medical Research
Investigating immune clusters in oesophageal cancer
Funded by: Cure Cancer

Nassar, Zeyad
The University of Adelaide
Targeting Fatty Acid Oxidation, a Novel Approach for Prostate Cancer Treatment
Funded by: Cancer Australia and Can Too

Poh, Ashleigh
Olivia Newton-John Cancer Research Institute, La Trobe University
Targeting the myeloid-specific kinase HCK in non-small cell lung cancer to improve response to therapy
Funded by: Cancer Australia and Lung Foundation Australia

Syed, Shafiq
University of Newcastle
A fatty link between stem cells and endometrial cancer: Understanding the role of Axin2+ stem cells in endometrial regeneration, cancer, and metastasis
Funded by: Cancer Australia and Cure Cancer

Thijssen, Rachel
The Walter and Eliza Hall Institute of Medical Research
Elucidating leukaemia cell plasticity in resistance to targeted therapy
Funded by: Leukaemia Foundation

Tjin, Gavin
St Vincent's Institute of Medical Research
Identification of megakaryocyte and platelet bone marrow niches
Funded by: My Room Children’s Cancer Charity Ltd and The Kids’ Cancer Project

Trau, Matt
University of Queensland
nanoIMPAC: Monitoring immune toxicities and tumour immune evasion in lung cancer
Funded by: Cancer Australia

Vandyke, Kate
University of Adelaide
An age-old problem: the role of senescent bone marrow stromal cells in MGUS to multiple myeloma progression
Funded by: Cancer Australia and Leukaemia Foundation

Cancer Australia's funding partners and successful applicants each PdCCRS round.
















Find out more about: